Ultralife Net Receivables vs Capital Surpluse Analysis
ULBI Stock | USD 11.79 0.08 0.67% |
Ultralife financial indicator trend analysis is much more than just breaking down Ultralife prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ultralife is a good investment. Please check the relationship between Ultralife Net Receivables and its Capital Surpluse accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ultralife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in Ultralife Stock please use our How to Invest in Ultralife guide.
Net Receivables vs Capital Surpluse
Net Receivables vs Capital Surpluse Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ultralife Net Receivables account and Capital Surpluse. At this time, the significance of the direction appears to have strong relationship.
The correlation between Ultralife's Net Receivables and Capital Surpluse is 0.61. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Ultralife, assuming nothing else is changed. The correlation between historical values of Ultralife's Net Receivables and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Ultralife are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Net Receivables i.e., Ultralife's Net Receivables and Capital Surpluse go up and down completely randomly.
Correlation Coefficient | 0.61 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Net Receivables
Capital Surpluse
Most indicators from Ultralife's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ultralife current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ultralife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in Ultralife Stock please use our How to Invest in Ultralife guide.As of now, Ultralife's Tax Provision is increasing as compared to previous years. The Ultralife's current Sales General And Administrative To Revenue is estimated to increase to 0.23, while Selling General Administrative is projected to decrease to under 17.2 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 242K | 951K | 2.0M | 1.3M | Depreciation And Amortization | 3.5M | 4.5M | 3.9M | 2.9M |
Ultralife fundamental ratios Correlations
Click cells to compare fundamentals
Ultralife Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ultralife fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 144.6M | 137.7M | 159.1M | 168.4M | 178.3M | 98.2M | |
Short Long Term Debt Total | 17.2M | 1.4M | 20.9M | 21.3M | 29.2M | 30.6M | |
Other Current Liab | 6.4M | 6.5M | 6.9M | (1.2M) | 9.5M | 10.0M | |
Total Current Liabilities | 17.2M | 18.7M | 18.4M | 28.9M | 23.7M | 17.5M | |
Total Stockholder Equity | 109.7M | 116.8M | 117.6M | 116.3M | 125.3M | 74.3M | |
Property Plant And Equipment Net | 22.5M | 22.9M | 24.0M | 21.7M | 24.7M | 18.1M | |
Net Debt | 9.7M | (9.3M) | 12.4M | 15.6M | 18.9M | 19.8M | |
Retained Earnings | (52.8M) | (47.6M) | (47.8M) | (48.0M) | (40.8M) | (42.8M) | |
Accounts Payable | 9.4M | 10.8M | 9.5M | 16.1M | 11.3M | 9.1M | |
Cash | 7.4M | 10.7M | 8.4M | 5.7M | 10.3M | 7.1M | |
Non Current Assets Total | 74.2M | 73.2M | 93.3M | 89.4M | 88.1M | 92.5M | |
Non Currrent Assets Other | 2.0M | 2.3M | 2.7M | 2.3M | (15.0M) | (14.2M) | |
Cash And Short Term Investments | 7.4M | 10.7M | 8.4M | 5.7M | 10.3M | 8.7M | |
Net Receivables | 30.1M | 21.1M | 20.0M | 27.8M | 31.8M | 16.0M | |
Common Stock Shares Outstanding | 16.2M | 16.1M | 16.0M | 16.1M | 16.2M | 14.5M | |
Liabilities And Stockholders Equity | 144.6M | 137.7M | 159.1M | 168.4M | 178.3M | 98.2M | |
Non Current Liabilities Total | 17.6M | 2.1M | 22.9M | 23.1M | 29.1M | 30.6M | |
Inventory | 29.8M | 28.2M | 33.2M | 41.2M | 42.2M | 22.0M | |
Other Current Assets | 3.1M | 4.6M | 4.1M | 4.3M | 5.9M | 5.3M | |
Other Stockholder Equity | 163.1M | 164.1M | 165.0M | 165.9M | 167.7M | 139.4M | |
Total Liab | 34.8M | 20.8M | 41.3M | 52.0M | 52.8M | 55.5M | |
Property Plant And Equipment Gross | 22.5M | 22.9M | 91.4M | 92.7M | 87.6M | 92.0M | |
Total Current Assets | 70.4M | 64.5M | 65.7M | 79.0M | 90.2M | 54.7M | |
Accumulated Other Comprehensive Income | (2.5M) | (1.8M) | (1.7M) | (3.8M) | (3.7M) | (3.5M) | |
Short Term Debt | 439K | 1.4M | 1.4M | 2M | 2.9M | 3.0M | |
Common Stock Total Equity | 2.0M | 2.0M | 2.0M | 2.0M | 2.3M | 1.8M | |
Common Stock | 2.0M | 2.0M | 2.1M | 2.1M | 2.1M | 1.9M | |
Other Assets | 13.3M | 14.1M | 14.1M | 14.4M | 16.5M | 17.4M | |
Treasury Stock | (18.5M) | (19.3M) | (21.2M) | (21.3M) | (19.2M) | (18.2M) | |
Intangible Assets | 9.7M | 9.2M | 17.1M | 15.9M | 15.1M | 8.0M | |
Property Plant Equipment | 22.5M | 22.9M | 24.0M | 21.7M | 19.5M | 13.9M | |
Other Liab | 590K | 2.1M | 4.1M | 1.9M | 2.2M | 1.6M | |
Good Will | 26.8M | 27.0M | 38.2M | 37.4M | 37.6M | 25.2M | |
Net Tangible Assets | 83.0M | 89.8M | 62.4M | 62.9M | 72.4M | 74.5M | |
Noncontrolling Interest In Consolidated Entity | (154K) | (85K) | 24K | 123K | 141.5K | 148.5K | |
Retained Earnings Total Equity | (82.9M) | (58.0M) | (52.8M) | (47.6M) | (54.7M) | (57.5M) | |
Capital Surpluse | 180.2M | 182.6M | 184.3M | 185.5M | 213.3M | 196.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ultralife offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ultralife's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ultralife Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ultralife Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ultralife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in Ultralife Stock please use our How to Invest in Ultralife guide.Note that the Ultralife information on this page should be used as a complementary analysis to other Ultralife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Ultralife Stock analysis
When running Ultralife's price analysis, check to measure Ultralife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultralife is operating at the current time. Most of Ultralife's value examination focuses on studying past and present price action to predict the probability of Ultralife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultralife's price. Additionally, you may evaluate how the addition of Ultralife to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Stocks Directory Find actively traded stocks across global markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Ultralife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultralife. If investors know Ultralife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultralife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.898 | Earnings Share 0.64 | Revenue Per Share 10.36 | Quarterly Revenue Growth 0.314 | Return On Assets 0.048 |
The market value of Ultralife is measured differently than its book value, which is the value of Ultralife that is recorded on the company's balance sheet. Investors also form their own opinion of Ultralife's value that differs from its market value or its book value, called intrinsic value, which is Ultralife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultralife's market value can be influenced by many factors that don't directly affect Ultralife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultralife's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultralife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultralife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.